Allosteric enhancers for adenosine receptors

Drug Development Research

Volumn 58, Issue 4, 2003, Pages 493-495

  Olsson, Ray A ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

2 amino 3 aroylthiophenes; A1 adenosine receptor; A3 adenosine receptor; Adenosine

Indexed keywords

2 AMINO 4,5 DIMETHYL 3 (3 TRIFLUOROMETHYLBENZOYL)THIOPHENE; 2 AMINOTHIAZOLE DERIVATIVE; 3 (2 PYRIDINYL)ISOQUINOLONE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A3 RECEPTOR AGONIST; IMIDAZOQUINOLINE DERIVATIVE; QUINOLINE DERIVATIVE; THIOPHENE DERIVATIVE; UNCLASSIFIED DRUG;

ALLOSTERISM; CARCINOGENICITY; CONFERENCE PAPER; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENCY; HEART ATRIOVENTRICULAR NODE; HEART CONDUCTION; HEART PROTECTION; STRUCTURE ACTIVITY RELATION;

EID: 0037711402     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10198     Document Type: Conference Paper

References (21)

1. 1 adenosine selective enhancer of the negative dromotropic action of adenosine in the guinea pig heart. J Pharmacol Exp Ther 226:611-617.
2. 1 receptor. Bioorg Med Chem Lett 10:1953-1957.
3. 1 receptor coupling to G proteins. Biochim Biophys Acta 1265:15-21.
4. 1 adenosine receptors. Mol Pharmacol 50:104-111.
5. 1 receptor binding and function by 2-amino-3-benzoylthiophenes. Mol Pharmacol 38:129-148.
6. 1 receptor binding by 2-amino-3-benzoylthiophenes. Mol Pharmacol 38:950-958.
7. Chordia MD, Murphree LJ, Olsson RA, Linden J, Macdonald TL. 2002. 2-Aminothiazole derivatives: a new class of allosteric enhancers of A1 adenosine receptors. Bioorg Med Chem Lett 12:1563-1566.
8. Fawzi AB, Macdonald D, Benbow LL, Smith-Torhan A, Zhang H, Weig BC, Ho G, Tulshian D, Linder ME, Graziano MP. 2001. SCH-202676: an allosteric modulator of both agonist and antagonist binding to G protein-coupled receptors. Mol Pharmacol 59:30-37.
9. Gewald K, Schinke E, Böttcher H. 1966. Heterocyclen aus CH-aciden Nitrilen. VIII. 2-Amino-thiophene aus methylenaktiven Nitrilen, Carbonylverbindungen und Schwefel. Chem Ber 99:94-100.
10. 3 adenosine receptors by a series of 3-(2-pyridinyl)isoquinoline derivatives. Mol Pharmacol 60:1057-1063.
11. 3 adenosine receptors by a series of imidazoquinoline derivatives. Mol Pharmacol 62:81-89.
12. Kollias-Baker C, Ruble J, Dennis D, Bruns RF, Linden J, Belardinelli L. 1994a. Allosteric enhancer PD 81,723 acts by novel mechanism to potentiate cardiac actions of adenosine. Circ Res 75:961-971.
13. Kollias-Baker C, Xu J, Pelleg A, Belardinelli L. 1994b. Novel approach for enhancing atrioventricular nodal conduction delay mediated by endogenous adenosine. Circ Res 75:972-980.
14. 1 receptor. J Pharmacol Exp Ther 281:761-768.
15. 1 receptor functions by benzoylthiophenes in guinea pig tissues in vitro. Naunyn Schmied Arch Pharmacol 352:206-212.
16. Mizumura T, Auchampach JA, Linden J, Bruns RF, Gross GJ. 1996. PD 81,723, an allosteric enhancer of the A1 adenosine receptor, lowers the threshold for ischemic preconditioning in dogs. Circ Res 79:415-423.
17. Mudumbi RV, Montamat SC, Bruns RF, Vestal RE. 1993. Cardiac functional responses to adenosine by PD 81,723, an allosteric enhancer of the adenosine A1 receptor. Am J Physiol 264:H1017-H1022.
18. 1 receptor-dependent and -independent effects of the allosteric enhancer PD 81,723. J Pharmacol Exp Ther 288:446-454.
19. Picano E, Abbraccio MP. 1998. European Stroke Prevention Study- 2 results: serendipitous demonstration of neuroprotection induced by endogenous adenosine accumulation? Trends Pharmacol Sci 19:14-16.
20. Tinney FJ, Sanchez JP, Nogas JA. 1974. Synthesis and pharmacological evaluation of 2,3-dihydro-1H-thieno[2,3-e]diazepines. J Med Chem 17:624-630.
21. 1 receptor. Synthesis and biological evaluation of novel 2-amino-3-benzoylthiophenes as allosteric enhancers of agonist binding. J Med Chem 42:3629-3635.